Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

Why Stryker Is Soaring Today

Traders cheer after the company reports upbeat fourth-quarter results and shares a bullish outlook.

How to Play It Safe in Biotech

Risk-averse investors might be surprised how safe some of these companies are in one of the most volatile sectors on the market.

3 Low-Risk Tech Stocks for a Downturn

The market is making some investors nervous, but you don’t have to give up tech altogether to make your portfolio safer.

Why Appian Slumped 15% in 2018

Declining revenue growth rates might not have pleased traders, but it wasn't a bad year for the business.

Why Globus Medical Is Soaring Today

Traders cheer after the company reports pleasing preliminary results for the fourth quarter and shares bullish guidance.